What are Adaptive Biotechnologies's profit margins?

Adaptive Biotechnologies (ADPT) runs a 75.3% gross margin and a -15.8% operating margin, with a -16.8% net margin.

Where do Adaptive Biotechnologies's ratios come from?

Every ratio is computed from Adaptive Biotechnologies's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Adaptive Biotechnologies ADPT Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Gross margin	74.2%+14.5pp	59.7%+4.1pp	55.6%-13.1pp	68.7%+0.7pp
Operating margin	-20.6%+70.2pp	-90.8%+42.5pp	-133.3%-25.3pp	-108%+27.4pp
Net margin	-21.5%+67.6pp	-89.1%+43.2pp	-132.3%-24.3pp	-108%+26.3pp
Returns
Return on equity	-28.2%+34.2pp	-62.4%-4.1pp	-58.3%-20.8pp	-37.5%-6.7pp
Return on invested capital	-15.5%+22.7pp	-38.2%+3.8pp	-42%-8.2pp	-33.8%-1.8pp
Efficiency
Asset turnover	0.5×+0.2×	0.3×+0.1×	0.2×0.0×	0.2×+0.1×
Liquidity
Current ratio	3.3×+0.4×	2.9×-1.8×	4.7×-0.5×	5.1×+1.6×
Leverage
Debt-to-equity	1×-0.1×	1.1×+0.4×	0.7×+0.2×	0.5×+0.3×
Per Share
Book value per share	$1.44+4.7%	$1.38-35.5%	$2.14-34.4%	$3.26-24.3%
Valuation
Market capitalization	$2.48B+180%	$884.74M+24.7%	$709.39M-35.1%	$1.09B-72.4%
Price / sales	9×+4.0×	4.9×+0.8×	4.2×-1.7×	5.9×-19.8×
Price / book	11.3×+7.0×	4.4×+2.1×	2.3×-0.1×	2.4×-4.2×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Adaptive Biotechnologies.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Adaptive Biotechnologies's profit margins?: Adaptive Biotechnologies (ADPT) runs a 75.3% gross margin and a -15.8% operating margin, with a -16.8% net margin.
Where do Adaptive Biotechnologies's ratios come from?: Every ratio is computed from Adaptive Biotechnologies's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.